Biofunctionalized targeted nanoparticles for therapeutic applications (Q81610160)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18613759%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

review article

1 reference

title

Biofunctionalized targeted nanoparticles for therapeutic applications (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18613759%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18613759%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Frank X. Gu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18613759%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Omid C. Farokhzad

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18613759%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

Liangfang Zhang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18613759%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Juliana M Chan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18613759%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Aleksander Radovic-Moreno

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18613759%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Mariam R Shaikh

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18613759%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

publication date

1 August 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18613759%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Biological Therapy

10 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18613759%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18613759%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

page(s)

1063-1070

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18613759%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18613759%20AND%20SRC:MED&resulttype=core&format=json

Phase II Evaluations of Cilengitide in Asymptomatic Patients with Androgen-Independent Prostate Cancer: Scientific Rationale and Study Design

10 January 2020

cites work

1 reference

12 December 2020

Designing materials for biology and medicine

1 reference

12 December 2020

Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer

1 reference

12 December 2020

Designer genes: recombinant antibody fragments for biological imaging.

1 reference

12 December 2020

Dendrimers in biomedical applications--reflections on the field

1 reference

12 December 2020

Folate-mediated delivery of macromolecular anticancer therapeutic agents

1 reference

12 December 2020

New methods of drug delivery

1 reference

12 December 2020

Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA.

1 reference

12 December 2020

Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo

1 reference

12 December 2020

In vitro selection of functional nucleic acids

1 reference

12 December 2020

Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase

1 reference

12 December 2020

Micellar nanocarriers: pharmaceutical perspectives

1 reference

12 December 2020

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

1 reference

12 December 2020

Controlled and modulated release of basic fibroblast growth factor

1 reference

12 December 2020

Development and regulation of monoclonal antibody products: challenges and opportunities

1 reference

12 December 2020

Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer

1 reference

12 December 2020

Minibody: A novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts.

1 reference

12 December 2020

About Dendrimers: Structure, Physical Properties, and Applications

1 reference

12 December 2020

Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer

1 reference

12 December 2020

Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing mice.

1 reference

12 December 2020

Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies.

1 reference

12 December 2020

Stealth PLA-PEG nanoparticles as protein carriers for nasal administration

1 reference

12 December 2020

Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery

1 reference

12 December 2020

1 reference

12 December 2020

Liposome-encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first-line therapy of metastatic breast carcinoma

1 reference

12 December 2020

Tumor targeting based on the effect of enhanced permeability and retention (EPR) and the mechanism of receptor-mediated endocytosis (RME).

1 reference

12 December 2020

In vitro genetic analysis of the Tetrahymena self-splicing intron

1 reference

12 December 2020

Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery

1 reference

12 December 2020

How to stabilize phospholipid liposomes (using nanoparticles).

1 reference

12 December 2020

Target-specific cellular uptake of PLGA nanoparticles coated with poly(L-lysine)-poly(ethylene glycol)-folate conjugate

1 reference

12 December 2020

Small antibody mimetics comprising two complementarity-determining regions and a framework region for tumor targeting

1 reference

12 December 2020

Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells

1 reference

12 December 2020

Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance

1 reference

12 December 2020

Antigenic crossreactivity of the alpha subunit of complement component C8 with the cysteine-rich domain shared by complement component C9 and low density lipoprotein receptor

1 reference

12 December 2020

Preclinical safety testing of biotechnology-derived pharmaceuticals: understanding the issues and addressing the challenges

1 reference

12 December 2020

Selection of high affinity RNA ligands to the bacteriophage R17 coat protein

1 reference

12 December 2020

Drug delivery and targeting

1 reference

12 December 2020

Recent advances with liposomes as pharmaceutical carriers

1 reference

12 December 2020

A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer

1 reference

12 December 2020

An in vitro selected binding protein (affibody) shows conformation-dependent recognition of the respiratory syncytial virus (RSV) G protein

1 reference

12 December 2020

Selection in vitro of single-stranded DNA molecules that fold into specific ligand-binding structures

1 reference

12 December 2020

Efficient cancer therapy with a nanobody-based conjugate

1 reference

12 December 2020

Nanoparticle-based diagnosis and therapy

1 reference

12 December 2020

Long-circulating and target-specific nanoparticles: theory to practice

1 reference

12 December 2020

The emerging nanomedicine landscape

1 reference

12 December 2020

Controlled assembly of dendrimer-like DNA.

1 reference

12 December 2020

Antibody Targeting of Long-Circulating Lipidic Nanoparticles Does Not Increase Tumor Localization but Does Increase Internalization in Animal Models

1 reference

12 December 2020

Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers.

1 reference

12 December 2020

The origin of pegnology

1 reference

12 December 2020

Targeted nanoparticle-based drug delivery and diagnosis

1 reference

12 December 2020

Controllable self-assembly of nanoparticles for specific delivery of multiple therapeutic molecules to cancer cells using RNA nanotechnology

1 reference

12 December 2020

Biodegradable long-circulating polymeric nanospheres

1 reference

12 December 2020

Biopharmaceutical drug discovery using novel protein scaffolds

1 reference

12 December 2020

Polymers for the sustained release of proteins and other macromolecules

1 reference

12 December 2020

2'-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain

1 reference

12 December 2020

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

1 reference

12 December 2020

1 reference

12 December 2020

Aptamer therapeutics advance

1 reference

12 December 2020

SELEXION. Systematic evolution of ligands by exponential enrichment with integrated optimization by non-linear analysis

1 reference

12 December 2020

Nanotechnology based drug delivery system(s) for the management of tuberculosis.

1 reference

12 December 2020

Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging

1 reference

12 December 2020

Polymer conjugates as anticancer nanomedicines

1 reference

12 December 2020

Preparation and characterization of carbonyl iron/poly(butylcyanoacrylate) core/shell nanoparticles.

1 reference

12 December 2020

Development of ligand-targeted liposomes for cancer therapy

1 reference

12 December 2020

In vitro characterization of a bivalent anti-HER-2 affibody with potential for radionuclide-based diagnostics

1 reference

12 December 2020

Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo

1 reference

12 December 2020

Nuclease-resistant nucleic acid ligands to vascular permeability factor/vascular endothelial growth factor

1 reference

12 December 2020

10.1517/14712598.8.8.1063

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18613759%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18613759%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference